0001423221-21-000009 | 10-Q | XBRL Viewer | Quanex Building Products Corp

Print Document View Excel Document

Cover page - shares	6 Months Ended
Cover page - shares	Apr. 30, 2021	May 31, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2021
Document Transition Report	false
Entity File Number	1-33913
Entity Registrant Name	QUANEX BUILDING PRODUCTS CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1561397
Entity Address, Address Line One	1800 West Loop South
Entity Address, Address Line Two	Suite 1500
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77027
City Area Code	713
Local Phone Number	961-4600
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	NX
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001423221
Current Fiscal Year End Date	--10-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Common Stock, Shares Outstanding		33,596,045

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Apr. 30, 2021	Oct. 31, 2020
Current assets:
Cash and cash equivalents	$ 49,258	$ 51,621
Accounts receivable, net of allowance for credit losses of $133 and $161	96,521	88,287
Inventories, net	80,365	61,181
Prepaid and other current assets	8,361	6,217
Total current assets	234,505	207,306
Property, plant and equipment, net of accumulated depreciation of $344,395 and $340,144	178,466	184,104
Operating lease right-of-use assets	56,424	51,824
Goodwill	150,302	146,154
Intangible assets, net	88,850	93,068
Other assets	7,025	9,129
Total assets	715,572	691,585
Current liabilities:
Accounts payable	83,081	77,335
Accrued liabilities	41,207	38,289
Income taxes payable	2,463	6,465
Current maturities of long-term debt	745	692
Current operating lease liabilities	8,226	7,459
Total current liabilities	135,722	130,240
Long-term debt	87,195	116,728
Noncurrent operating lease liabilities	48,989	44,873
Deferred pension and postretirement benefits	10,819	10,923
Deferred income taxes	22,078	19,116
Other liabilities	15,672	13,946
Total liabilities	320,475	335,826
Commitments and contingencies
Stockholders’ equity:
Preferred stock, no par value, shares authorized 1,000,000; issued and outstanding - none	0	0
Common stock, $0.01 par value, shares authorized 125,000,000; issued 37,273,510 and 37,296,166, respectively; outstanding 33,588,545 and 32,804,737, respectively	373	373
Additional paid-in-capital	253,147	253,458
Retained earnings	230,590	213,517
Accumulated other comprehensive loss	(23,392)	(33,024)
Less: Treasury stock at cost, 3,684,965 and 4,491,429 shares, respectively	(65,621)	(78,565)
Total stockholders’ equity	395,097	355,759
Total liabilities and stockholders' equity	$ 715,572	$ 691,585

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2021	Oct. 31, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 133	$ 161
Accumulated depreciation of property, plant and equipment	$ 344,395	$ 340,144
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	37,273,510	37,296,166
Common stock, shares outstanding	33,588,545	32,804,737
Treasury stock, shares	3,684,965	4,491,429

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Income Statement [Abstract]
Net sales	$ 270,357	$ 187,475	$ 500,504	$ 384,072
Cost and expenses:
Cost of sales (excluding depreciation and amortization)	208,460	149,732	384,857	307,159
Selling, general and administrative	29,672	16,713	60,533	40,845
Restructuring charges	0	251	39	404
Depreciation and amortization	10,845	11,886	21,860	24,791
Operating income	21,380	8,893	33,215	10,873
Non-operating (expense) income:
Interest expense	(640)	(1,563)	(1,391)	(3,145)
Other, net	265	300	457	336
Income before income taxes	21,005	7,630	32,281	8,064
Income tax expense	(6,454)	(2,129)	(9,878)	(2,553)
Net income	$ 14,551	$ 5,501	$ 22,403	$ 5,511
Basic earnings per common share	$ 0.44	$ 0.17	$ 0.68	$ 0.17
Diluted earnings per common share	$ 0.43	$ 0.17	$ 0.67	$ 0.17
Weighted-average common shares outstanding:
Basic (in shares)	33,355	32,676	33,110	32,770
Diluted (in shares)	33,637	32,793	33,444	32,907
Cash dividends per share (in usd per share)	$ 0.08	$ 0.08	$ 0.16	$ 0.16

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 14,551	$ 5,501	$ 22,403	$ 5,511
Other comprehensive income (loss):
Foreign currency translation gain (loss)	1,032	(6,999)	9,632	(4,256)
Change in pension from net unamortized gain adjustment (pretax)	0	0	0	2,519
Change in pension from net unamortized gain adjustment tax expense	0	0	0	(609)
Other comprehensive income (loss)	1,032	(6,999)	9,632	(2,346)
Comprehensive income (loss)	$ 15,583	$ (1,498)	$ 32,035	$ 3,165

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Operating activities:
Net income	$ 22,403	$ 5,511
Adjustments to reconcile net income to cash (used for) provided by operating activities:
Depreciation and amortization	21,860	24,791
Stock-based compensation	970	86
Deferred income tax	2,339	1,194
Other, net	5,049	463
Changes in assets and liabilities:
(Increase) decrease in accounts receivable	(6,726)	14,682
Increase in inventory	(18,265)	(8,363)
Increase in other current assets	(2,013)	(559)
Increase (decrease) in accounts payable	5,584	(16,807)
Increase (decrease) in accrued liabilities	994	(13,673)
Decrease in income taxes payable	(4,071)	(4,052)
(Decrease) increase in deferred pension and postretirement benefits	(104)	562
Increase (decrease) in other long-term liabilities	642	(787)
Other, net	298	(576)
Cash provided by operating activities	28,960	2,472
Investing activities:
Capital expenditures	(9,799)	(16,313)
Proceeds from disposition of capital assets	1,665	33
Cash used for investing activities	(8,134)	(16,280)
Financing activities:
Borrowings under credit facility	0	114,500
Repayments of credit facility borrowings	(30,000)	(41,000)
Repayments of other long-term debt	(605)	(505)
Common stock dividends paid	(5,330)	(5,287)
Issuance of common stock	16,123	2,954
Cash paid for payroll tax for shares forfeited upon vesting	492	454
Purchase of treasury stock	(3,968)	(6,693)
Cash (used for) provided by financing activities	(24,272)	63,515
Effect of exchange rate changes on cash and cash equivalents	1,083	(323)
(Decrease) increase in cash and cash equivalents	(2,363)	49,384
Cash and cash equivalents at beginning of period	51,621	30,868
Cash and cash equivalents at end of period	$ 49,258	$ 80,252

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Balance at beginning of period at Oct. 31, 2019	$ 330,187	$ 374	$ 254,673	$ 185,703	$ (33,817)	$ (76,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	10			10
Foreign currency translation adjustment	2,743				2,743
Common dividends ($0.08 per share)	(2,659)			(2,659)
Treasury shares purchased, at cost	(4,639)					(4,639)
Change in pension from net unamortized loss (net of tax expense of $609)	1,910				1,910
Stock-based compensation activity:
Expense related to stock-based compensation	(239)		(239)
Stock options exercised	3,075		92	(159)		3,142
Restricted stock awards granted	0		(1,082)	94		988
Performance restricted stock units vested			(495)			495
Other	(455)	(1)	(454)
Balance at end of period at Jan. 31, 2020	$ 329,933	373	252,495	182,989	(29,164)	(76,760)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Balance at beginning of period at Oct. 31, 2019	$ 330,187	374	254,673	185,703	(33,817)	(76,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,511
Balance at end of period at Apr. 30, 2020	$ 323,957	373	252,717	185,779	(36,163)	(78,749)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.16
Balance at beginning of period at Jan. 31, 2020	$ 329,933	373	252,495	182,989	(29,164)	(76,760)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,501			5,501
Foreign currency translation adjustment	(6,999)				(6,999)
Common dividends ($0.08 per share)	(2,628)			(2,628)
Treasury shares purchased, at cost	(2,054)					(2,054)
Stock-based compensation activity:
Expense related to stock-based compensation	325		325
Stock options exercised	(121)		(38)	(83)		0
Restricted stock awards granted	0		(65)	0		65
Balance at end of period at Apr. 30, 2020	$ 323,957	373	252,717	185,779	(36,163)	(78,749)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Balance at beginning of period at Oct. 31, 2020	$ 355,759	373	253,458	213,517	(33,024)	(78,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,852			7,852
Foreign currency translation adjustment	8,600				8,600
Common dividends ($0.08 per share)	(2,637)			(2,637)
Treasury shares purchased, at cost	(1,927)					(1,927)
Stock-based compensation activity:
Expense related to stock-based compensation	523		523
Stock options exercised	10,030		635			9,395
Restricted stock awards granted	0		(1,282)			1,282
Performance restricted stock units vested			(565)			565
Other	(492)		(492)
Balance at end of period at Jan. 31, 2021	$ 377,708	373	252,277	218,732	(24,424)	(69,250)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Balance at beginning of period at Oct. 31, 2020	$ 355,759	373	253,458	213,517	(33,024)	(78,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	22,403
Balance at end of period at Apr. 30, 2021	$ 395,097	373	253,147	230,590	(23,392)	(65,621)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.16
Balance at beginning of period at Jan. 31, 2021	$ 377,708	373	252,277	218,732	(24,424)	(69,250)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	14,551			14,551
Foreign currency translation adjustment	1,032				1,032
Common dividends ($0.08 per share)	(2,693)			(2,693)
Treasury shares purchased, at cost	(2,041)					(2,041)
Stock-based compensation activity:
Expense related to stock-based compensation	447		447
Stock options exercised	6,093		423			5,670
Balance at end of period at Apr. 30, 2021	$ 395,097	$ 373	$ 253,147	$ 230,590	$ (23,392)	$ (65,621)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) (Parenthetical)	3 Months Ended
	Jan. 31, 2020 USD ($) $ / shares
Statement of Stockholders' Equity [Abstract]
Cash dividends per share (in usd per share) \| $ / shares	$ 0.08
Change in pension from net unamortized loss, tax \| $	$ 609,000

Nature of Operations and Basis of Presentation

6 Months Ended

Apr. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations and Basis of Presentation

Quanex Building Products Corporation is a component supplier to original equipment manufacturers (OEMs) in the building products industry. These components can be categorized as window and door (fenestration) components and kitchen and bath cabinet components. Examples of fenestration components include: (1) energy-efficient flexible insulating glass spacers, (2) extruded vinyl profiles, (3) window and door screens, and (4) precision-formed metal and wood products. We also manufacture cabinet doors and other components for OEMs in the kitchen and bathroom cabinet industry. In addition, we provide certain other non-fenestration components and products, which include solar panel sealants, trim moldings, vinyl decking, vinyl fencing, water retention barriers, and conservatory roof components. We have organized our business into three reportable business segments. For additional discussion of our reportable business segments, see Note 11, “Segment Information.” We use low-cost, short lead-time production processes and engineering expertise to provide our customers with specialized products for their specific window, door, and cabinet applications. We believe these capabilities provide us with unique competitive advantages. We serve a primary customer base in North America and the United Kingdom (U.K.), and also serve customers in international markets through our operating plants in the U.K. and Germany, as well as through sales and marketing efforts in other countries.

Unless the context indicates otherwise, references to “Quanex”, the “Company”, “we”, “us” and “our” refer to the consolidated business operations of Quanex Building Products Corporation and its subsidiaries.

The accompanying interim unaudited condensed consolidated financial statements include the accounts of Quanex Building Products Corporation. All intercompany accounts and transactions have been eliminated in consolidation. These financial statements have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of October 31, 2020 was derived from audited financial information but does not include all disclosures required by U.S. GAAP. The accompanying financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended October 31, 2020. In our opinion, the accompanying financial statements contain all adjustments (which consist of normal recurring adjustments, except as disclosed herein) necessary to fairly present our financial position, results of operations and cash flows for the interim periods. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year or for any future periods.

In preparing financial statements, we make informed judgments and estimates that affect the reported amounts of assets and liabilities as of the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting period. We review our estimates on an on-going basis, including those related to impairment of long-lived assets and goodwill, contingencies and income taxes. Changes in facts and circumstances may result in revised estimates and actual results may differ from these estimates.

Revenue from Contracts with Customers

Revenue recognition

We recognize revenue that reflects the consideration we expect to receive for product sales upon transfer to customers. Revenue for product sales is recognized when control of the promised products is transferred to our customers, and we are entitled to consideration in exchange for such transfer. We account for a contract when a customer provides us with a firm purchase order that identifies the products to be provided, the payment terms for those products, and when collectability of the consideration due is probable.

Performance obligations

A performance obligation is a promise to provide the customer with a good or service. Our performance obligations include product sales, with each product included in a customer contract being recognized as a separate performance obligation. For contracts with multiple performance obligations, the standalone selling price of each product is generally readily observable.

Revenue from product sales is recognized at a point in time when the product is transferred to the customer, in accordance with the shipping terms, which is generally upon shipment. We estimate a provision for sales returns and warranty allowances to account for product returns related to general returns and product nonconformance.

We generally expense incremental costs of obtaining a contract when incurred because the amortization period would be less than one year. Additionally, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

Pricing and sales incentives

Pricing is established at or prior to the time of sale with our customers and we record sales at the agreed-upon net selling price, reflective of current and prospective discounts.

Shipping and handling costs

We account for shipping and handling services as fulfillment services; accordingly, freight revenue is combined with the product deliverable rather than being accounted for as a distinct performance obligation within the terms of the agreement. Shipping and handling costs incurred by us for the delivery of goods to customers are considered a cost to fulfill the contract and are included in cost of sales in the accompanying condensed consolidated statements of income.

Contract assets and liabilities

Deferred revenue, which is not significant, is recorded when we have remaining unsatisfied performance obligations for which we have received consideration.

Disaggregation of revenue

We produce a wide variety of products that are used in the fenestration industry, including window spacer systems; extruded vinyl products; metal fabricated products; and astragals, thresholds and screens. In addition, we produce certain non-fenestration products, including kitchen and bath cabinet doors and components, flooring and trim moldings, solar edge tape, plastic decking, fencing, water retention barriers, conservatory roof components, and other products.

The following table summarizes our product sales for the three and six months ended April 30, 2021 and 2020 into groupings by segment which we believe depicts how the nature, amount, timing and uncertainty of our revenues and cash flows are affected by economic factors. For further details regarding our results by segment, refer to Note 11, “Segment Information”.


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2021		2020		2021		2020
	(In thousands)
North American Fenestration:
United States - fenestration	$	128,218	$	95,791	$	240,518	$	192,638
International - fenestration	8,397		6,153		16,175		12,587
United States - non-fenestration	6,293		4,372		11,690		8,935
International - non-fenestration	3,235		2,277		5,876		4,885
	$	146,143	$	108,593	$	274,259	$	219,045
European Fenestration:

International - fenestration	$	50,835	$	24,865	$	92,189	55,829
International - non-fenestration	10,822		4,335		18,559		10,137
	$	61,657	$	29,200	$	110,748	$	65,966
North American Cabinet Components:
United States - fenestration	$	3,497	$	2,647	$	6,471	$	5,795
United States - non-fenestration	60,388		47,540		110,890		93,989
International - non-fenestration	(323)		477		195		924
	$	63,562	$	50,664	$	117,556	$	100,708
Unallocated Corporate & Other
Eliminations	$	(1,005)	$	(982)	$	(2,059)	$	(1,647)
	$	(1,005)	$	(982)	$	(2,059)	$	(1,647)
Net sales	$	270,357	$	187,475	$	500,504	$	384,072

Allowance for Credit Losses

We have established an allowance for credit losses to estimate the risk of losses, which represents an estimate of expected losses over the remaining contractual life of our receivables. The allowance is determined using two methods. The amounts calculated from each of these methods are combined to determine the total amount reserved. First, a specific reserve is established for individual accounts where information indicates the customers may have an inability to meet financial obligations. Second, a reserve is determined for all customers based on a range of percentages applied to aging categories. These percentages are based on historical collection rates, write-off experience, and forecasts of future economic conditions. Actual write-offs are charged against the allowance when collection efforts have been unsuccessful.

COVID-19 Impact

On March 11, 2020, the World Health Organization (WHO) declared the outbreak of COVID-19 as a global pandemic and advised aggressive containment action. The COVID-19 pandemic and its impacts are continuing to have an adverse effect on many sectors of the economy. Measures providing for business shutdowns generally exclude certain essential services commonly including critical infrastructure such as construction and the businesses that support that critical infrastructure. To date, we have not experienced significant challenges or expenses implementing crisis management plans intended for containment and prevention. While we could expect some negative impacts on our business, results of operations, cash flows and financial position, the overall financial impact cannot be reasonably estimated at this time.

The health and safety of our employees are high priority. In response to the COVID-19 pandemic, we have taken additional measures to limit possible infections at the workplace by implementing social distancing, sanitizing the workspace, and requiring employees to wear masks and other measures necessary to ensure safety as infection surges dictate. We continue to assess and refine these measures on an ongoing basis as public health guidance and applicable laws and regulations continue to evolve.

As a result of the economic and business impact of COVID-19, we may be required to revise certain accounting estimates and judgments such as, but not limited to, those related to the valuation of goodwill, intangibles, right-of-use assets, long-lived assets, accounts receivable (including allowances for credit losses), and inventory, which could have a material adverse effect on our financial position and results of operations.

Inventories

6 Months Ended

Apr. 30, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of the following at April 30, 2021 and October 31, 2020 (in thousands):


	April 30, 2021		October 31, 2020
Raw materials	$	40,506	$	33,298
Finished goods and work in process	41,881		32,347
Supplies and other	2,170		2,020
Total	84,557		67,665
Less: Inventory reserves	4,192		6,484
Inventories, net	$	80,365	$	61,181

Fixed costs related to excess manufacturing capacity, if any, have been expensed in the period they were incurred and, therefore, are not capitalized into inventory.

Goodwill and Intangible Assets

6 Months Ended

Apr. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill

The change in the carrying amount of goodwill for the six months ended April 30, 2021 was as follows (in thousands):


	Six Months Ended
	April 30, 2021
Beginning balance as of November 1, 2020	$	146,154


Foreign currency translation adjustment	4,148
Balance as of the end of the period	$	150,302

At our last annual test date, August 31, 2020, we evaluated the recoverability of goodwill at each of our five reporting units with goodwill balances and determined that our goodwill was not impaired. We evaluated for indicators of impairment during the three and six months ended April 30, 2021 and determined that there were no triggering events related to the impacts of COVID-19 or any other areas of our operations. However, the long term effects of the COVID-19 pandemic on the demand and pricing of our products may result in future impairment charges. For a summary of the change in the carrying amount of goodwill by segment, see Note 11, “Segment Information.”

Identifiable Intangible Assets

Amortizable intangible assets consisted of the following as of April 30, 2021 and October 31, 2020 (in thousands):


	April 30, 2021				October 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	$	146,592	$	76,203	$	154,004	$	80,441
Trademarks and trade names	56,554		38,622		55,745		37,314
Patents and other technology	22,545		22,016		22,386		21,312

Total	$	225,691	$	136,841	$	232,135	$	139,067

We had aggregate amortization expense related to intangible assets for the three and six months ended April 30, 2021 of $3.3 million and $6.7 million, respectively, and $3.6 million and $7.4 million, respectively, for the comparable prior year periods. We retired fully amortized identifiable assets of $9.9 million related to customer relationships during the six months ended April 30, 2021.

Estimated remaining amortization expense, based on current intangible balances, for each of the fiscal years ending October 31, is as follows (in thousands):


	Estimated Amortization Expense
2021 (remaining six months)	$	6,105
2022	12,163
2023	11,404
2024	10,652
2025	9,426
Thereafter	39,100
Total	$	88,850

Debt and Finance Lease Obligations

6 Months Ended

Apr. 30, 2021

Debt Disclosure [Abstract]

Debt and Finance Lease Obligations

Long-term debt consisted of the following at April 30, 2021 and October 31, 2020 (in thousands):


	April 30, 2021		October 31, 2020
Revolving Credit Facility	$	73,000	$	103,000


Finance lease obligations and other	15,689		15,321
Unamortized deferred financing fees	(749)		(901)
Total debt	$	87,940	$	117,420
Less: Current maturities of long-term debt	745		692
Long-term debt	$	87,195	$	116,728

Revolving Credit Facility

As more fully described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2020, on October 18, 2018, we amended and extended our prior credit facility by entering into a $325.0 million revolving credit facility (the “2018 Credit Facility”), with Wells Fargo Bank, National Association, as Agent, Swingline Lender and Issuing Lender, and Bank of America, N.A. serving as Syndication Agent. The 2018 Credit Facility has a five-year term, maturing on October 18, 2023, and requires interest payments calculated, at our election and depending upon our Consolidated Leverage Ratio, at either a Base Rate plus an applicable margin or the LIBOR Rate plus an applicable margin. At the time of the initial borrowing, the applicable rate was LIBOR + 1.50%. In addition, we are subject to commitment fees for the unused portion of the 2018 Credit Facility.

The applicable margin and commitment fees are outlined in the following table:


Pricing Level	Consolidated Leverage Ratio	Commitment Fee	LIBOR Rate Loans	Base Rate Loans
I	Less than or equal to 1.50 to 1.00	0.200%	1.25%	0.25%
II	Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00	0.225%	1.50%	0.50%
III	Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00	0.250%	1.75%	0.75%
IV	Greater than 3.00 to 1.00	0.300%	2.00%	1.00%

In the event of default, outstanding borrowings would accrue interest at the Default Rate, as defined, whereby the obligations will bear interest at a per annum rate equal to 2% above the total per annum rate otherwise applicable.

The 2018 Credit Facility provides for incremental revolving credit commitments for a minimum principal amount of $10.0 million, up to an aggregate amount of $150.0 million, subject to the lender's discretion to elect or decline the incremental increase. We can also borrow up to the lesser of $15.0 million or the revolving credit commitment, as defined, under a Swingline feature of the Credit Facility.

The 2018 Credit Facility contains a: (1) Consolidated Interest Coverage Ratio requirement whereby we must not permit the Consolidated Interest Coverage Ratio, as defined, to be less than 2.25 to 1.00, and (2) Consolidated Leverage Ratio requirement, whereby we must not permit the Consolidated Leverage Ratio, as defined, to be greater than 3.25 to 1.00.

In addition to maintaining these financial covenants, the 2018 Credit Facility also limits our ability to enter into certain business transactions, such as to incur indebtedness or liens, to acquire businesses or dispose of material assets, make restricted payments, pay dividends (limited to $20.0 million per year) and other transactions as further defined in the 2018 Credit Facility. Some of these limitations, however, do not take effect so long as total leverage is less than or equal to 2.75 to 1.00 and available liquidity exceeds $25 million. Substantially all of our domestic assets, with the exception of real property, are used as collateral for the Credit Agreement.

As of April 30, 2021, we had $73.0 million of borrowings outstanding under the 2018 Credit Facility (reduced by unamortized debt issuance costs of $0.7 million), $4.5 million of outstanding letters of credit and $15.7 million outstanding primarily under finance leases and other debt. We had $247.5 million available for use under the 2018 Credit Facility at April 30, 2021. Outstanding borrowings under the 2018 Credit Facility accrue interest at 1.36% per annum. Our weighted average borrowing rate for borrowings outstanding during the six months ended April 30, 2021 and 2020 was 1.47% and 3.03%, respectively. We were in compliance with our debt covenants as of April 30, 2021.

Retirement Plans

6 Months Ended

Apr. 30, 2021

Retirement Benefits [Abstract]

Retirement Plans

Pension Plan

Our non-contributory, single employer defined benefit pension plan covers a majority of our employees in the U.S. The net periodic pension cost for this plan for the three and six months ended April 30, 2021 and 2020 was as follows (in thousands):


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2021		2020		2021		2020
Service cost	$	212	$	242	$	425	$	780
Interest cost	189		280		378		573
Expected return on plan assets	(490)		(502)		(980)		(994)
Amortization of net loss	36		95		72		204
Net periodic pension (benefit) cost	$	(53)	$	115	$	(105)	$	563

On January 1, 2020, we enacted changes to our pension plan whereby the benefits for all participants were frozen and thereafter those participants will receive increased benefits in the Company sponsored defined contribution plan in lieu of participation in a defined benefit plan.

As a result of this action, we remeasured the pension assets and obligations for the pension plan, which resulted in a decrease to our projected benefit obligation and a corresponding net actuarial gain that was recorded in accumulated other comprehensive income.

During September 2020, we contributed $3.7 million to fund our plan, and we expect to make a contribution to our plan in September 2021 of approximately $0.5 million.

Other Plans

We also have a supplemental benefit plan covering certain executive officers and key employees and a non-qualified deferred compensation plan covering members of the Board of Directors and certain key employees. As of April 30, 2021 and October 31, 2020, our liability under the supplemental benefit plan was approximately $2.8 million and $2.6 million, respectively. As of April 30, 2021 and October 31, 2020, the liability associated with the deferred compensation plan was approximately $4.6 million and $3.3 million, respectively. We record the current portion of liabilities associated with these plans under the caption “Accrued Liabilities,” and the long-term portion under the caption “Other Liabilities” in the accompanying condensed consolidated balance sheets.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920

+ Details

Income Taxes	6 Months Ended
Income Taxes	Apr. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes To determine our income tax expense or benefit for interim periods, consistent with accounting standards, we apply the estimated annual effective income tax rate to year-to-date results. Our estimated annual effective tax rates for the six months ended April 30, 2021 and 2020 were 27.3% and 25.8%, respectively, excluding discrete items. The 2021 effective tax rate is higher than the U.S. Statutory rate of 21% primarily due to state income taxes and the $0.8 million true-up of our deferred taxes from prior year filings, partially offset by a discrete benefit of $0.6 million related to the vesting or exercise of equity-based compensation awards. The 2020 effective tax rate was primarily impacted by a discrete charge of $0.4 million related to the vesting or exercise of equity-based compensation awards. As of April 30, 2021, our liability for uncertain tax positions (UTP) of $0.5 million relates to certain state tax items regarding the interpretation of tax laws and regulations. Judgment is required in assessing the future tax consequences of events that have been recognized in our financial statements or tax returns. The outcome of the future tax consequences of legal proceedings, if any, as well as the outcome of competent authority proceedings, changes in regulatory tax laws, or interpretation of those tax laws could impact our financial statements. We are subject to the effect of these matters occurring in various jurisdictions. The disallowance of the UTP would not materially affect the annual effective tax rate. We do not believe any of the UTP at April 30, 2021 will be recognized within the next twelve months. We evaluate the likelihood of realization of our deferred tax assets by considering both positive and negative evidence. We maintain a valuation allowance for certain state net operating losses which totaled $1.5 million as of April 30, 2021 and October 31, 2020. Final regulations were published by the Internal Revenue Service regarding Uniform Capitalization (UNICAP) that became effective during fiscal 2020. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law. In addition, the Consolidated Appropriations Act, 2021 (CAA) was signed into law on December 27, 2020 and the American Rescue Plan Act of 2021 (American Rescue Plan) was signed into law on March 11, 2021. We evaluated the UNICAP regulations and the CARES Act and determined that there were no material impacts on our condensed consolidated financial statements. We are evaluating the CAA and the American Rescue Plan and do not believe there will be a material impact on our condensed consolidated financial statements.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details

Contingencies	6 Months Ended
Contingencies	Apr. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Contingencies	7. Contingencies Remediation and Environmental Compliance Costs Under applicable state and federal laws, we may be responsible for, among other things, all or part of the costs required to remove or remediate wastes or hazardous substances at locations we, or our predecessors, have owned or operated. From time to time, we also have been alleged to be liable for all or part of the costs incurred to clean up third-party sites where there might have been an alleged improper disposal of hazardous substances. At present, we are not involved in any such matters. From time to time, we incur routine expenses and capital expenditures associated with compliance with existing environmental regulations, including control of air emissions and water discharges, and plant decommissioning costs. We have not incurred any material expenses or capital expenditures related to environmental matters during the past six fiscal years, and do not expect to incur a material amount of such costs in fiscal 2021. While we will continue to have future expenditures related to environmental matters, any such amounts are impossible to reasonably estimate at this time. Based upon our experience to date, we do not believe that our compliance with environmental requirements will have a material adverse effect on our operations, financial condition or cash flows. Litigation From time to time, we, along with our subsidiaries, are involved in various litigation matters arising in the ordinary course of our business, including those arising from or related to contractual matters, commercial disputes, intellectual property, personal injury, environmental matters, product performance or warranties, product liability, insurance coverage and personnel and employment disputes. We regularly review with legal counsel the status of all ongoing proceedings, and we maintain insurance against these risks to the extent deemed prudent by our management and to the extent such insurance is available. However, there is no assurance that we will prevail in these matters or that our insurers will accept full coverage of these matters, and we could, in the future, incur judgments, enter into settlements of claims, or revise our expectations regarding the outcome or insurability of matters we face, which could materially impact our results of operations. We have been and are currently party to multiple claims, some of which are in litigation, relating to alleged defects in a commercial sealant product that was manufactured and sold during the 2000’s. While we believe that our product was not defective and that we would prevail in these commercial sealant product claims if taken to trial, the timing, ultimate resolution and potential impact of these claims is not currently determinable. Nevertheless, after taking into account all currently available information, including our defenses, the advice of our counsel, and the extent and currently-expected availability of our existing insurance coverage, we believe that the eventual outcome of these commercial sealant claims will not have a material adverse effect on our overall financial condition, results of operations or cash flows, and we have not recorded any accrual with regard to these claims.

Fair Value Measurement of Assets and Liabilities	6 Months Ended
Fair Value Measurement of Assets and Liabilities	Apr. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurement of Assets and Liabilities	Fair Value Measurement of Assets and Liabilities Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market data developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to Level 1 and the lowest priority to Level 3. The three levels of the fair value hierarchy are described below: •Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. •Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly or indirectly including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates) and inputs that are derived principally from or corroborated by observable market data by correlation or other means. •Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Carrying amounts reported on the balance sheet for cash, cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term maturity of these instruments. Our outstanding debt is variable rate debt that re-prices frequently, thereby limiting our exposure to significant change in interest rate risk. As a result, the fair value of our debt instrument approximates carrying value at April 30, 2021, and October 31, 2020 (Level 2 measurement). Our performance share awards are marked-to-market on a quarterly basis during a three-year vesting period based on market data (Level 2 measurement). For further information, refer to Note 9, “Stock-Based Compensation - Performance Share Awards.”

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Stock-Based Compensation

6 Months Ended

Apr. 30, 2021

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

We have established and maintain an Omnibus Incentive Plan (2020 Plan) that provides for the granting of restricted stock awards, stock options, restricted stock units, performance share awards, performance restricted stock units, and other stock-based and cash-based awards. The 2020 Plan is administered by the Compensation and Management Development Committee of the Board of Directors.

The aggregate number of shares of common stock authorized for grant under the 2020 Plan is 3,139,895 as approved by shareholders. Any officer, key employee and/or non-employee director is eligible for awards under the 2020 Plan. We grant restricted stock units to non-employee directors on the first business day of each fiscal year. As approved by the Compensation & Management Development Committee of our Board of Directors annually, we grant a mix of restricted stock awards, restricted stock units, performance shares and/or performance restricted stock units to officers, management and key employees. We also historically granted stock options to certain officers, directors and key employees. Occasionally, we may make additional grants to key employees at other times during the year.

Restricted Stock Awards

Restricted stock awards are granted to key employees and officers annually, and typically cliff vest over a three-year period with service and continued employment as the only vesting criteria. The recipient of the restricted stock award is entitled to all of the rights of a shareholder, except that the award is nontransferable during the vesting period. The fair value of the restricted stock award is established on the grant date and then expensed over the vesting period resulting in an increase in additional paid-in-capital. Shares are generally issued from treasury stock at the time of grant.

A summary of non-vested restricted stock awards activity during the six months ended April 30, 2021 is presented below:


	Restricted Stock Awards	Weighted Average Grant Date Fair Value per Share
Non-vested at October 31, 2020	187,500	$	16.82
Granted	73,300	20.68
Forfeited	—	—
Vested	(44,400)	20.70
Non-vested at April 30, 2021	216,400	$	17.28

The total weighted average grant-date fair value of restricted stock awards that vested during each of the six months ended April 30, 2021 and 2020 was $0.9 million and $1.1 million, respectively. As of April 30, 2021, total unrecognized compensation cost related to unamortized restricted stock awards was $2.1 million. We expect to recognize this expense over the remaining weighted average vesting period of 2.1 years.

Stock Options

Historically, stock options have been awarded to key employees, officers and non-employee directors. In December 2017, the Compensation & Management Development Committee of the Board of Directors approved a change to the long-term incentive award program eliminating the grant of stock options and replacing this award with a grant of performance restricted stock units as further described below. As a result, the final stock options were granted during the fiscal year ended October 31, 2017. Stock options typically vested ratably over a three-year period with service and continued employment as the vesting conditions. Our stock options may be exercised up to a maximum of ten years from the date of grant. The fair value of the stock options was determined on the grant date and expensed over the vesting period resulting in an increase in additional paid-in-capital. For employees who were nearing retirement-eligibility, we recognized stock option expense ratably over the shorter of the vesting period or the period from the grant-date to the retirement-eligibility date.

We use a Black-Scholes pricing model to estimate the fair value of stock options. A description of the methodology for the valuation assumptions was disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2020.

The following table summarizes our stock option activity for the six months ended April 30, 2021:


	Stock Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (000s)
Outstanding at October 31, 2020	1,095,329	$	18.88
Granted	—
Exercised	(857,893)	18.79
Forfeited/Expired	(2,500)	18.22
Outstanding at April 30, 2021	234,936	$	19.22	3.8	$	1,896
Vested at April 30, 2021	234,936	$	19.22	3.8	$	1,896
Exercisable at April 30, 2021	234,936	$	19.22	3.8	$	1,896

Intrinsic value is the amount by which the market price of the common stock on the date of exercise exceeds the exercise price of the stock option. The total intrinsic value of stock options exercised during the six months ended April 30, 2021 and 2020 was $4.2 million and $0.5 million, respectively. The weighted-average grant date fair value of stock options that vested during the six months ended April 30, 2020 was $0.4 million.

Restricted Stock Units

Restricted stock units may be awarded to key employees and officers from time to time, and annually to non-employee directors. The non-employee director restricted stock units vest immediately but are payable only upon the director's cessation of service unless an election is made by the non-employee director to settle and pay the award on an earlier specified date. Restricted stock units awarded to employees and officers typically cliff vest after a three-year period with service and continued employment as the vesting conditions. Restricted stock units are not considered outstanding shares and do not have voting rights, although the holder does receive a cash payment equivalent to the dividend paid, on a one-for-one basis, on our

outstanding common shares. Once the criteria is met, each restricted stock unit is payable to the holder in cash based on the market value of one share of our common stock. Accordingly, we record a liability for the restricted stock units on our balance sheet and recognize any changes in the market value during each reporting period as compensation expense.

During the six months ended April 30, 2021 and 2020, non-employee directors received 28,826 and 25,326 restricted stock units, respectively, at a grant date fair value of $18.79 per share and $19.02 per share, respectively, which vested immediately. As of April 30, 2021, there were 21,774 non-vested restricted stock units, which were awarded in January 2020 to key employees at a weighted average grant date fair value of $17.08. During the six months ended April 30, 2021 we paid $0.8 million to settle vested restricted stock units. There were no corresponding payments to settle vested restricted stock during the six months ended April 30, 2020.

Performance Share Awards

We have awarded annual grants of performance shares to key employees and officers. Beginning with the fiscal year ended October 31, 2019, performance share awards issued vest with return on net assets (RONA) as the vesting condition and pay out 100% in cash, and are accounted for as liability.

The expected cash settlement of the performance share award is recorded as a liability and is being marked to market over the three-year term of the award and can fluctuate depending on the number of shares ultimately expected to vest. Depending on the achievement of the performance conditions, 0% to 200% of the awarded performance shares may ultimately vest.

The following table summarizes our performance share grants and the grant date fair value for the RONA performance metrics:



Grant Date	Shares Awarded	Return on Net Assets		Shares Forfeited

December 5, 2018	132,400	$	13.63	40,900
December 5, 2019	55,900	$	19.40	5,300
December 2, 2020	65,300	$	20.68	—

In December 2020, the December 2017 grant vested, however, no shares were awarded as performance criteria were not met. We recorded compensation expense of $0.6 million and $3.3 million, respectively, for the three and six months ended April 30, 2021 related to the expected payout of our performance share awards that were outstanding as of April 30, 2021. We recorded compensation expense of $0.1 million for the three months ended April 30, 2020 and a decrease in compensation expense of $0.4 million for the six months ended April 30, 2020 related to the expected payout of our performance share awards that were outstanding as of April 30, 2020.

Performance share awards are not considered outstanding shares and do not have voting rights, although dividends are accrued over the performance period and will be payable in cash based upon the number of performance shares ultimately earned.

Performance Restricted Stock Units

We award performance restricted stock units to key employees and officers. These awards cliff vest upon a three-year service period with the absolute total shareholder return of our common stock over this three-year term as the vesting criteria. The number of shares earned is variable depending on the metric achieved, and the settlement method is 100% in our common stock, with accrued dividends paid in cash at the time of vesting, assuming the shares had been outstanding throughout the performance period.

To value the performance restricted stock units, we used a Monte Carlo simulation model to arrive at a grant-date fair value. This amount will be adjusted for forfeitures and expensed over the three-year term of the award with a credit to additional paid-in-capital. Depending on the achievement of the performance conditions, a minimum of 0% and a maximum of 150% of the awarded performance restricted stock units may vest. Specifically, the awards vest on a continuum with the following Absolute Total Shareholder Return (A-TSR) milestones:

Vesting Level

Vesting Criteria

Percentage of Award Vested

Level 1

A-TSR greater than or equal to 50%

150%

Level 2

A-TSR less than 50% and greater than or equal to 20%

100%

Level 3

A-TSR less than 20% and greater than or equal to -20%

50%

Level 4

A-TSR less than -20%

—%

The following table summarizes our performance restricted stock unit grants and the grant date fair value for the A-TSR performance metric:


Grant Date	Shares Awarded	Grant Date Fair Value		Shares Forfeited

December 5, 2018	89,200	$	13.63	25,500
December 5, 2019	35,000	$	19.40	—
December 2, 2020	38,400	$	20.68	—

During the six months ended April 30, 2021, 32,322 performance restricted stock units vested. We recorded compensation expense related to our performance restricted stock units of approximately $0.2 million and $0.4 million, respectively, for the three and six months ending April 30, 2021 and $0.1 million and $0.3 million, respectively, for the comparable prior year periods.

The performance restricted stock units are not considered outstanding shares, do not have voting rights, and are excluded from diluted weighted-average shares used to calculate earnings per share until the performance criteria is probable to result in the issuance of contingent shares. As of April 30, 2021, we have deemed 91,460 shares related to the December 2018 grant of performance restricted stock units as probable to vest.

Treasury Shares

We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Shares are generally issued from treasury stock at the time of grant of restricted stock awards, upon the exercise of stock options, and upon the vesting of performance shares and performance restricted stock units. On the subsequent issuance of treasury shares, we record proceeds in excess of cost as an increase in additional paid in capital. A deficiency of such proceeds relative to costs would be applied to reduce paid-in-capital associated with prior issuances to the extent available, with the remainder recorded as a charge to retained earnings. There were no charges to retained earnings during the six months ended April 30, 2021.

The following table summarizes the treasury stock activity during the six months ended April 30, 2021:


			Six Months Ended
			April 30, 2021
Beginning Balance as of November 1, 2020			4,491,429
Restricted stock awards granted			(73,300)
Performance restricted stock units vested			(32,322)
Stock options exercised			(857,893)
Treasury stock repurchases			157,051
Balance at April 30, 2021			3,684,965

Other Income

6 Months Ended

Apr. 30, 2021

Other Income and Expenses [Abstract]

Other Income

Other income, included under the caption “Other, net” on the accompanying condensed consolidated statements of income, consisted of the following for the three and six months ended April 30, 2021 and 2020 (in thousands):


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2021		2020		2021		2020
Foreign currency transaction gains (losses)	$	(4)	$	132	$	(82)	$	83
Foreign currency derivative losses	—		(4)		—		(15)
Pension service benefit	265		127		530		217
Interest income	1		14		4		19
Other	3		31		5		32
Other, net	$	265	$	300	$	457	$	336

Segment Information

6 Months Ended

Apr. 30, 2021

Segment Reporting [Abstract]

Segment Information

We present three reportable business segments (1) NA Fenestration, comprising three operating segments primarily focused on the fenestration market in North America including vinyl profiles, insulating glass spacers, screens & other fenestration components; (2) EU Fenestration, comprising our U.K.-based vinyl extrusion business, manufacturing vinyl profiles & conservatories, and the European insulating glass business manufacturing insulating glass spacers; and (3) NA Cabinet Components, comprising our cabinet door and components operations. We maintain an Unallocated Corporate & Other which includes transaction expenses, stock-based compensation, long-term incentive awards based on the performance of our common stock and other factors, certain severance, legal, and other costs not deemed to be allocable to all segments, depreciation of corporate assets, interest expense, other, net, income taxes and inter-segment eliminations, and executive incentive compensation and medical expense fluctuations relative to planned costs as determined during the annual planning process. Other general and administrative costs associated with the corporate office are allocated to the reportable segments, based upon a relative measure of profitability in order to more accurately reflect each reportable business segment's administrative costs. We allocate corporate expenses to businesses acquired mid-year from the date of acquisition. The accounting policies of our operating segments are the same as those used to prepare the accompanying condensed consolidated financial statements. Corporate general and administrative expense allocated during the three and six month period ended April 30, 2021 was $5.4 million and $10.7 million, respectively, and $4.6 million and $10.2 million for the comparable prior year periods.

ASC Topic 280-10-50, “Segment Reporting” (ASC 280) permits aggregation of operating segments based on factors including, but not limited to: (1) similar nature of products serving the building products industry, primarily the fenestration business; (2) similar production processes, although there are some differences in the amount of automation amongst operating plants; (3) similar types or classes of customers, namely the primary OEMs; (4) similar distribution methods for product delivery, although the extent of the use of third-party distributors will vary amongst the businesses; (5) similar regulatory environment; and (6) converging long-term economic similarities.

Segment information for the three and six months ended April 30, 2021 and 2020, and total assets as of April 30, 2021 and October 31, 2020 are summarized in the following table (in thousands):


	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Three Months Ended April 30, 2021
Net sales	$	146,143	$	61,657	$	63,562	$	(1,005)	$	270,357
Depreciation and amortization	4,846		2,607		3,305		87		10,845
Operating income (loss)	15,783		10,250		(284)		(4,369)		21,380
Capital expenditures	2,001		1,268		1,160		124		4,553
Three Months Ended April 30, 2020
Net sales	$	108,593	$	29,200	$	50,664	$	(982)	$	187,475
Depreciation and amortization	5,961		2,330		3,474		121		11,886
Operating income (loss)	7,428		612		(1,174)		2,027		8,893
Capital expenditures	4,308		407		2,269		17		7,001
Six Months Ended April 30, 2021
Net sales	$	274,259	$	110,748	$	117,556	$	(2,059)	$	500,504
Depreciation and amortization	9,957		5,125		6,575		203		21,860
Operating income (loss)	26,986		18,437		(297)		(11,911)		33,215
Capital expenditures	4,821		1,740		3,113		125		9,799
Six Months Ended April 30, 2020
Net sales	$	219,045	$	65,966	$	100,708	$	(1,647)	$	384,072
Depreciation and amortization	12,940		4,738		6,875		238		24,791
Operating income (loss)	9,058		3,776		(3,288)		1,327		10,873
Capital expenditures	11,236		1,626		3,344		107		16,313
As of April 30, 2021
Total assets	$	261,311	$	238,109	$	175,769	$	40,383	$	715,572
As of October 31, 2020
Total assets	$	252,703	$	223,248	$	174,713	$	40,921	$	691,585

The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the six months ended April 30, 2021 (in thousands):


	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Balance as of October 31, 2020	$	38,712	$	68,295	$	39,147	$	—	$	146,154


Foreign currency translation adjustment	—		4,148		—		—		4,148
Balance as of April 30, 2021	$	38,712	$	72,443	$	39,147	$	—	$	150,302

For further details of Goodwill, see Note 3, “Goodwill & Intangible Assets”, located herewith.

We did not allocate non-operating loss or income tax benefit to the reportable segments. The following table reconciles operating income as reported above to net income for the three and six months ended April 30, 2021 and 2020 (in thousands):


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2021		2020		2021		2020
Operating income	$	21,380	$	8,893	$	33,215	$	10,873
Interest expense	(640)		(1,563)		(1,391)		(3,145)
Other, net	265		300		457		336
Income tax expense	(6,454)		(2,129)		(9,878)		(2,553)
Net income	$	14,551	$	5,501	$	22,403	$	5,511

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Earnings Per Share

6 Months Ended

Apr. 30, 2021

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per ShareWe compute basic earnings per share by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per common and potential common shares include the weighted average of additional shares associated with the incremental effect of dilutive employee stock options, non-vested restricted stock as determined using the treasury stock method prescribed by U.S. GAAP and contingent shares associated with performance share awards, if dilutive.

Basic and diluted earnings per share for the three and six months ended April 30, 2021 and 2020 were calculated as follows (in thousands, except per share data):


	Net Income		Weighted Average Shares	Per Share
Three Months Ended April 30, 2021
Basic earnings per common share	$	14,551	33,355	$	0.44
Effect of dilutive securities:
Stock options	—		78	—
Restricted stock awards	—		112	—

Performance restricted stock units	—		92	—
Diluted earnings per common share	$	14,551	33,637	$	0.43
Three Months Ended April 30, 2020
Basic earnings per common share	$	5,501	32,676	$	0.17
Effect of dilutive securities:
Stock options	—		1	—
Restricted stock awards	—		73	—
Performance shares	—		18	—
Performance restricted stock units	—		25	—
Diluted earnings per common share	$	5,501	32,793	$	0.17
Six Months Ended April 30, 2021
Basic earnings per common share	$	22,403	33,110	$	0.68
Effect of dilutive securities:
Stock options	—		135	—
Restricted stock awards	—		108	—

Performance restricted stock units	—		91	—
Diluted earnings per common share	$	22,403	33,444	$	0.67
Six Months Ended April 30, 2020
Basic earnings per common share	$	5,511	32,770	$	0.17
Effect of dilutive securities:
Stock options	—		12	—
Restricted stock awards	—		83	—
Performance shares	—		17	—
Performance restricted stock units	—		25	—
Diluted earnings per common share	$	5,511	32,907	$	0.17

We do not include equity instruments in our calculation of diluted earnings per share if those instruments would be anti-dilutive. Such dilution is dependent on the excess of the market price of our stock over the exercise price and other components of the treasury stock method. The following table shows anti-dilutive instruments for the three and six months ended April 30, 2021 and 2020 (shares in thousands):


	Three Months Ended		Six Months Ended
	April 30,		April 30,
	2021	2020	2021	2020
Stock options	—	1,174	—	1,116
Restricted stock awards	—	51	—	51
Total	—	1,225	—	1,167

New Accounting Guidance	6 Months Ended
New Accounting Guidance	Apr. 30, 2021
Accounting Changes and Error Corrections [Abstract]
New Accounting Guidance	New Accounting Guidance Accounting Standards Recently Adopted In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326). This ASU sets forth a “current expected credit loss” model, which requires the measurement of all expected credit losses for financial instruments or other assets (e.g., trade receivables), held at the reporting date based on historical experience, current conditions, and reasonable supportable forecasts. We adopted this amendment on November 1, 2020, with no material impact on our condensed consolidated financial statements.

Nature of Operations and Basis of Presentation (Tables)

6 Months Ended

Apr. 30, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Disaggregation of Revenue


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2021		2020		2021		2020
	(In thousands)
North American Fenestration:
United States - fenestration	$	128,218	$	95,791	$	240,518	$	192,638
International - fenestration	8,397		6,153		16,175		12,587
United States - non-fenestration	6,293		4,372		11,690		8,935
International - non-fenestration	3,235		2,277		5,876		4,885
	$	146,143	$	108,593	$	274,259	$	219,045
European Fenestration:

International - fenestration	$	50,835	$	24,865	$	92,189	55,829
International - non-fenestration	10,822		4,335		18,559		10,137
	$	61,657	$	29,200	$	110,748	$	65,966
North American Cabinet Components:
United States - fenestration	$	3,497	$	2,647	$	6,471	$	5,795
United States - non-fenestration	60,388		47,540		110,890		93,989
International - non-fenestration	(323)		477		195		924
	$	63,562	$	50,664	$	117,556	$	100,708
Unallocated Corporate & Other
Eliminations	$	(1,005)	$	(982)	$	(2,059)	$	(1,647)
	$	(1,005)	$	(982)	$	(2,059)	$	(1,647)
Net sales	$	270,357	$	187,475	$	500,504	$	384,072

Inventories (Tables)

6 Months Ended

Apr. 30, 2021

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of the following at April 30, 2021 and October 31, 2020 (in thousands):


	April 30, 2021		October 31, 2020
Raw materials	$	40,506	$	33,298
Finished goods and work in process	41,881		32,347
Supplies and other	2,170		2,020
Total	84,557		67,665
Less: Inventory reserves	4,192		6,484
Inventories, net	$	80,365	$	61,181

Fixed costs related to excess manufacturing capacity, if any, have been expensed in the period they were incurred and, therefore, are not capitalized into inventory.

Goodwill and Intangible Assets (Tables)

6 Months Ended

Apr. 30, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in the Carrying Amount of Goodwill

The change in the carrying amount of goodwill for the six months ended April 30, 2021 was as follows (in thousands):


	Six Months Ended
	April 30, 2021
Beginning balance as of November 1, 2020	$	146,154


Foreign currency translation adjustment	4,148
Balance as of the end of the period	$	150,302

The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the six months ended April 30, 2021 (in thousands):


	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Balance as of October 31, 2020	$	38,712	$	68,295	$	39,147	$	—	$	146,154


Foreign currency translation adjustment	—		4,148		—		—		4,148
Balance as of April 30, 2021	$	38,712	$	72,443	$	39,147	$	—	$	150,302

Schedule of Acquired Finite-Lived Intangible Assets by Major Class

Identifiable Intangible Assets

Amortizable intangible assets consisted of the following as of April 30, 2021 and October 31, 2020 (in thousands):


	April 30, 2021				October 31, 2020
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	$	146,592	$	76,203	$	154,004	$	80,441
Trademarks and trade names	56,554		38,622		55,745		37,314
Patents and other technology	22,545		22,016		22,386		21,312

Total	$	225,691	$	136,841	$	232,135	$	139,067

Estimated Amortization Expense Related to Intangible Assets

Estimated remaining amortization expense, based on current intangible balances, for each of the fiscal years ending October 31, is as follows (in thousands):


	Estimated Amortization Expense
2021 (remaining six months)	$	6,105
2022	12,163
2023	11,404
2024	10,652
2025	9,426
Thereafter	39,100
Total	$	88,850

Debt and Finance Lease Obligations (Tables)

6 Months Ended

Apr. 30, 2021

Debt Disclosure [Abstract]

Debt and Finance Lease Obligations

Long-term debt consisted of the following at April 30, 2021 and October 31, 2020 (in thousands):


	April 30, 2021		October 31, 2020
Revolving Credit Facility	$	73,000	$	103,000


Finance lease obligations and other	15,689		15,321
Unamortized deferred financing fees	(749)		(901)
Total debt	$	87,940	$	117,420
Less: Current maturities of long-term debt	745		692
Long-term debt	$	87,195	$	116,728

Schedule of Applicable Margin and Commitment Fees

The applicable margin and commitment fees are outlined in the following table:


Pricing Level	Consolidated Leverage Ratio	Commitment Fee	LIBOR Rate Loans	Base Rate Loans
I	Less than or equal to 1.50 to 1.00	0.200%	1.25%	0.25%
II	Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00	0.225%	1.50%	0.50%
III	Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00	0.250%	1.75%	0.75%
IV	Greater than 3.00 to 1.00	0.300%	2.00%	1.00%

Retirement Plans (Tables)

6 Months Ended

Apr. 30, 2021

Retirement Benefits [Abstract]

Net Periodic Pension Cost

The net periodic pension cost for this plan for the three and six months ended April 30, 2021 and 2020 was as follows (in thousands):


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2021		2020		2021		2020
Service cost	$	212	$	242	$	425	$	780
Interest cost	189		280		378		573
Expected return on plan assets	(490)		(502)		(980)		(994)
Amortization of net loss	36		95		72		204
Net periodic pension (benefit) cost	$	(53)	$	115	$	(105)	$	563

Stock-Based Compensation (Tables)

6 Months Ended

Apr. 30, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Nonvested Restricted Share Activity

A summary of non-vested restricted stock awards activity during the six months ended April 30, 2021 is presented below:


	Restricted Stock Awards	Weighted Average Grant Date Fair Value per Share
Non-vested at October 31, 2020	187,500	$	16.82
Granted	73,300	20.68
Forfeited	—	—
Vested	(44,400)	20.70
Non-vested at April 30, 2021	216,400	$	17.28

Schedule of Stock Option Activity

The following table summarizes our stock option activity for the six months ended April 30, 2021:


	Stock Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (000s)
Outstanding at October 31, 2020	1,095,329	$	18.88
Granted	—
Exercised	(857,893)	18.79
Forfeited/Expired	(2,500)	18.22
Outstanding at April 30, 2021	234,936	$	19.22	3.8	$	1,896
Vested at April 30, 2021	234,936	$	19.22	3.8	$	1,896
Exercisable at April 30, 2021	234,936	$	19.22	3.8	$	1,896

Schedule of Performance Share Awards

The following table summarizes our performance share grants and the grant date fair value for the RONA performance metrics:



Grant Date	Shares Awarded	Return on Net Assets		Shares Forfeited

December 5, 2018	132,400	$	13.63	40,900
December 5, 2019	55,900	$	19.40	5,300
December 2, 2020	65,300	$	20.68	—

Schedule of Performance Restricted Stock Vesting Conditions

Specifically, the awards vest on a continuum with the following Absolute Total Shareholder Return (A-TSR) milestones:

Vesting Level

Vesting Criteria

Percentage of Award Vested

Level 1

A-TSR greater than or equal to 50%

150%

Level 2

A-TSR less than 50% and greater than or equal to 20%

100%

Level 3

A-TSR less than 20% and greater than or equal to -20%

50%

Level 4

A-TSR less than -20%

—%

Performance Restricted Stock Units by Grant


Grant Date	Shares Awarded	Grant Date Fair Value		Shares Forfeited

December 5, 2018	89,200	$	13.63	25,500
December 5, 2019	35,000	$	19.40	—
December 2, 2020	38,400	$	20.68	—

Treasury Stock Activity

The following table summarizes the treasury stock activity during the six months ended April 30, 2021:


			Six Months Ended
			April 30, 2021
Beginning Balance as of November 1, 2020			4,491,429
Restricted stock awards granted			(73,300)
Performance restricted stock units vested			(32,322)
Stock options exercised			(857,893)
Treasury stock repurchases			157,051
Balance at April 30, 2021			3,684,965

Other Income (Expense) (Tables)

6 Months Ended

Apr. 30, 2021

Other Income and Expenses [Abstract]

Schedule of Other Non-operating Income (Expense)

Other Income


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2021		2020		2021		2020
Foreign currency transaction gains (losses)	$	(4)	$	132	$	(82)	$	83
Foreign currency derivative losses	—		(4)		—		(15)
Pension service benefit	265		127		530		217
Interest income	1		14		4		19
Other	3		31		5		32
Other, net	$	265	$	300	$	457	$	336

Segment Information (Tables)

6 Months Ended

Apr. 30, 2021

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Segment information for the three and six months ended April 30, 2021 and 2020, and total assets as of April 30, 2021 and October 31, 2020 are summarized in the following table (in thousands):


	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Three Months Ended April 30, 2021
Net sales	$	146,143	$	61,657	$	63,562	$	(1,005)	$	270,357
Depreciation and amortization	4,846		2,607		3,305		87		10,845
Operating income (loss)	15,783		10,250		(284)		(4,369)		21,380
Capital expenditures	2,001		1,268		1,160		124		4,553
Three Months Ended April 30, 2020
Net sales	$	108,593	$	29,200	$	50,664	$	(982)	$	187,475
Depreciation and amortization	5,961		2,330		3,474		121		11,886
Operating income (loss)	7,428		612		(1,174)		2,027		8,893
Capital expenditures	4,308		407		2,269		17		7,001
Six Months Ended April 30, 2021
Net sales	$	274,259	$	110,748	$	117,556	$	(2,059)	$	500,504
Depreciation and amortization	9,957		5,125		6,575		203		21,860
Operating income (loss)	26,986		18,437		(297)		(11,911)		33,215
Capital expenditures	4,821		1,740		3,113		125		9,799
Six Months Ended April 30, 2020
Net sales	$	219,045	$	65,966	$	100,708	$	(1,647)	$	384,072
Depreciation and amortization	12,940		4,738		6,875		238		24,791
Operating income (loss)	9,058		3,776		(3,288)		1,327		10,873
Capital expenditures	11,236		1,626		3,344		107		16,313
As of April 30, 2021
Total assets	$	261,311	$	238,109	$	175,769	$	40,383	$	715,572
As of October 31, 2020
Total assets	$	252,703	$	223,248	$	174,713	$	40,921	$	691,585

Changes in the Carrying Amount of Goodwill

The change in the carrying amount of goodwill for the six months ended April 30, 2021 was as follows (in thousands):


	Six Months Ended
	April 30, 2021
Beginning balance as of November 1, 2020	$	146,154


Foreign currency translation adjustment	4,148
Balance as of the end of the period	$	150,302

The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the six months ended April 30, 2021 (in thousands):


	NA Fenestration		EU Fenestration		NA Cabinet Comp.		Unallocated Corp. & Other		Total
Balance as of October 31, 2020	$	38,712	$	68,295	$	39,147	$	—	$	146,154


Foreign currency translation adjustment	—		4,148		—		—		4,148
Balance as of April 30, 2021	$	38,712	$	72,443	$	39,147	$	—	$	150,302

Reconciliation of Operating Profit (Loss) from Segments to Consolidated


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2021		2020		2021		2020
Operating income	$	21,380	$	8,893	$	33,215	$	10,873
Interest expense	(640)		(1,563)		(1,391)		(3,145)
Other, net	265		300		457		336
Income tax expense	(6,454)		(2,129)		(9,878)		(2,553)
Net income	$	14,551	$	5,501	$	22,403	$	5,511

Earnings Per Share (Tables)

6 Months Ended

Apr. 30, 2021

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

Basic and diluted earnings per share for the three and six months ended April 30, 2021 and 2020 were calculated as follows (in thousands, except per share data):


	Net Income		Weighted Average Shares	Per Share
Three Months Ended April 30, 2021
Basic earnings per common share	$	14,551	33,355	$	0.44
Effect of dilutive securities:
Stock options	—		78	—
Restricted stock awards	—		112	—

Performance restricted stock units	—		92	—
Diluted earnings per common share	$	14,551	33,637	$	0.43
Three Months Ended April 30, 2020
Basic earnings per common share	$	5,501	32,676	$	0.17
Effect of dilutive securities:
Stock options	—		1	—
Restricted stock awards	—		73	—
Performance shares	—		18	—
Performance restricted stock units	—		25	—
Diluted earnings per common share	$	5,501	32,793	$	0.17
Six Months Ended April 30, 2021
Basic earnings per common share	$	22,403	33,110	$	0.68
Effect of dilutive securities:
Stock options	—		135	—
Restricted stock awards	—		108	—

Performance restricted stock units	—		91	—
Diluted earnings per common share	$	22,403	33,444	$	0.67
Six Months Ended April 30, 2020
Basic earnings per common share	$	5,511	32,770	$	0.17
Effect of dilutive securities:
Stock options	—		12	—
Restricted stock awards	—		83	—
Performance shares	—		17	—
Performance restricted stock units	—		25	—
Diluted earnings per common share	$	5,511	32,907	$	0.17

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share


	Three Months Ended		Six Months Ended
	April 30,		April 30,
	2021	2020	2021	2020
Stock options	—	1,174	—	1,116
Restricted stock awards	—	51	—	51
Total	—	1,225	—	1,167

Nature of Operations and Basis of Presentation Summary of Product Sales (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Product Information [Line Items]
Total sales	$ 270,357	$ 187,475	$ 500,504	$ 384,072
Operating Segments \| NA Fenestration
Product Information [Line Items]
Total sales	146,143	108,593	274,259	219,045
Operating Segments \| NA Fenestration \| United States \| Fenestration [Member]
Product Information [Line Items]
Total sales	128,218	95,791	240,518	192,638
Operating Segments \| NA Fenestration \| United States \| Non-fenestration [Member]
Product Information [Line Items]
Total sales	6,293	4,372	11,690	8,935
Operating Segments \| NA Fenestration \| International \| Fenestration [Member]
Product Information [Line Items]
Total sales	8,397	6,153	16,175	12,587
Operating Segments \| NA Fenestration \| International \| Non-fenestration [Member]
Product Information [Line Items]
Total sales	3,235	2,277	5,876	4,885
Operating Segments \| EU Fenestration
Product Information [Line Items]
Total sales	61,657	29,200	110,748	65,966
Operating Segments \| EU Fenestration \| International \| Fenestration [Member]
Product Information [Line Items]
Total sales	50,835	24,865	92,189	55,829
Operating Segments \| EU Fenestration \| International \| Non-fenestration [Member]
Product Information [Line Items]
Total sales	10,822	4,335	18,559	10,137
Operating Segments \| NA Cabinet Components
Product Information [Line Items]
Total sales	63,562	50,664	117,556	100,708
Operating Segments \| NA Cabinet Components \| United States \| Fenestration [Member]
Product Information [Line Items]
Total sales	3,497	2,647	6,471	5,795
Operating Segments \| NA Cabinet Components \| United States \| Non-fenestration [Member]
Product Information [Line Items]
Total sales	60,388	47,540	110,890	93,989
Operating Segments \| NA Cabinet Components \| International \| Non-fenestration [Member]
Product Information [Line Items]
Total sales	(323)	477	195	924
Corporate Non-Segment
Product Information [Line Items]
Total sales	$ (1,005)	$ (982)	$ (2,059)	$ (1,647)

Inventories (Detail) - USD ($) $ in Thousands	Apr. 30, 2021	Oct. 31, 2020
Inventory, Raw Materials and Supplies, Net of Reserves [Abstract]
Raw materials	$ 40,506	$ 33,298
Finished goods and work in process	41,881	32,347
Supplies and other	2,170	2,020
Total	84,557	67,665
Less: Inventory reserves	4,192	6,484
Inventories, net	$ 80,365	$ 61,181

Goodwill and Intangible Assets - Goodwill (Details)		6 Months Ended
Goodwill and Intangible Assets - Goodwill (Details)	Aug. 31, 2020 USD ($) reporting_unit	Apr. 30, 2021 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Number of reporting units \| reporting_unit	5
Goodwill, impairment loss	$ 0
Goodwill [Roll Forward]
Beginning balance		$ 146,154,000
Foreign currency translation adjustment		4,148,000
Balance as of the end of the period		$ 150,302,000

Goodwill and Intangible Assets - Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020	Oct. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 225,691		$ 225,691		$ 232,135
Accumulated amortization	136,841		136,841		139,067
Intangible assets amortization expense	3,300	$ 3,600	6,700	$ 7,400
Estimated Amortization Expense
2021 (remaining six months)	6,105		6,105
2022	12,163		12,163
2023	11,404		11,404
2024	10,652		10,652
2025	9,426		9,426
Thereafter	39,100		39,100
Total	88,850		88,850		93,068
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	146,592		146,592		154,004
Accumulated amortization	76,203		76,203		80,441
Retirement of fully amortized intangibles			9,900
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	56,554		56,554		55,745
Accumulated amortization	38,622		38,622		37,314
Patents and other technology
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	22,545		22,545		22,386
Accumulated amortization	$ 22,016		$ 22,016		$ 21,312

Debt and Finance Lease Obligations (Details) - USD ($)	6 Months Ended
Debt and Finance Lease Obligations (Details) - USD ($)	Apr. 30, 2021	Apr. 30, 2020	Oct. 31, 2020	Oct. 18, 2018
Debt Instrument [Line Items]
Unamortized deferred financing fees	$ 749,000		$ 901,000
Total debt	87,940,000		117,420,000
Current maturities of long-term debt	745,000		692,000
Long-term Debt	87,195,000		116,728,000
Letters of credit, outstanding	4,500,000
Finance lease obligations and other	15,700,000
Credit Facility, amount available	$ 247,500,000
Debt Instrument, Interest Rate During Period	1.47%	3.03%
Term Loan Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.36%
Capital Lease Obligations
Debt Instrument [Line Items]
Total debt	$ 15,689,000		15,321,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolving Credit Facility	73,000,000.0
Total debt	$ 73,000,000		$ 103,000,000
2018 Credit Facility [Member] \| Line of Credit [Member]
Debt Instrument [Line Items]
Default interest rate	2.00%
Minimum Incremental Borrowing	$ 10,000,000.0
Maximum Incremental Borrowing	$ 150,000,000.0
Debt Instrument, Required Coverage Ratio	0.0225
Debt Instrument, Required Leverage Ratio	0.0325
Debt Instrument, Limitation on Annual Dividend	$ 20,000,000.0
Debt Instrument, Leverage Ratio Threshold for Limitations to Take Effect	2.75
Debt Instrument, Liquidity Threshold for Limitations to Take Effect	$ 25,000,000
2018 Credit Facility [Member] \| Line of Credit [Member] \| Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage	0.20%
2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage	0.225%
2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage	0.25%
2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage	0.30%
Revolving Credit Facility [Member] \| Line of Credit [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity				$ 325,000,000.0
Swing Line [Member] \| Line of Credit [Member]
Debt Instrument [Line Items]
Debt Instrument, Unused Borrowing Capacity, Amount	$ 15,000,000.0
Base Rate [Member] \| 2018 Credit Facility [Member] \| Line of Credit [Member] \| Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	0.25%
Base Rate [Member] \| 2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Base Rate [Member] \| 2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	0.75%
Base Rate [Member] \| 2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
London Interbank Offered Rate (LIBOR) [Member] \| 2018 Credit Facility [Member] \| Line of Credit [Member] \| Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	1.25%
London Interbank Offered Rate (LIBOR) [Member] \| 2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	1.50%
London Interbank Offered Rate (LIBOR) [Member] \| 2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	1.75%
London Interbank Offered Rate (LIBOR) [Member] \| 2018 Credit Facility [Member] \| Line of Credit [Member] \| Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%

Retirement Plans (Detail) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
Retirement Plans (Detail) - USD ($) $ in Thousands	Apr. 30, 2021	Oct. 31, 2020	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Retirement Benefits [Abstract]
Defined benefit plan, contributions by employer		$ 3,700		$ 500
Supplemental benefit plan liability	$ 2,800	2,600		2,800
Deferred compensation liability	4,600	$ 3,300		4,600
Net periodic benefit cost:
Service cost	212		$ 242	425	$ 780
Interest cost	189		280	378	573
Expected return on plan assets	(490)		(502)	(980)	(994)
Amortization of net loss	36		95	72	204
Net periodic pension (benefit) cost	$ (53)		$ 115	$ (105)	$ 563

Income Taxes (Detail) - USD ($) $ in Millions	6 Months Ended
Income Taxes (Detail) - USD ($) $ in Millions	Apr. 30, 2021	Apr. 30, 2020	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Percent	27.30%	25.80%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount	$ 0.8
Effective Income Tax Rate Reconciliation, Vesting or Exercise Of Share-based Payment Arrangement, Amount	0.6	$ 0.4
Liability for uncertain tax positions	0.5
Valuation allowance	$ 1.5		$ 1.5

Stock Based Compensation (Details)	Apr. 30, 2021 shares
Share-based Payment Arrangement [Abstract]
Number of shares authorized, originally	3,139,895

Stock-Based Compensation - Restricted Stock Awards (Details) - Restricted Stock Awards (RSAs) - USD ($)	6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020	Oct. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Number of Shares
Nonvested (in shares)	216,400		187,500
Grants (in shares)	73,300
Cancelled (in shares)	0
Vested (in shares)	(44,400)
Weighted Average Grant Date Fair Value per Share
Non-vested at beginning of the period (in usd per share)	$ 16.82
Granted (in usd per share)	20.68
Cancelled (in usd per share)	0
Vested (in usd per share)	20.70
Non-vested at end of the period (in usd per share)	$ 17.28
Fair value of restricted stock awards vested	$ 900,000	$ 1,100,000
Unrecognized compensation cost - non vested restricted stock awards	$ 2,100,000
Weighted-average period over which unrecognized cost is expected to be recognized	2 years 1 month 6 days

Stock-Based Compensation - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Stock Options, [Roll Forward]
Outstanding at beginning of period (in shares)	1,095,329
Granted (in shares)	0
Exercised (in shares)	(857,893)
Forfeited/Expired (in shares)	(2,500)
Outstanding at end of period (in shares)	234,936
Vested (in shares)	234,936
Exercisable at end of period (in shares)	234,936
Weighted Average Exercise Price
Outstanding at beginning of period (in usd per share)	$ 18.88
Granted (in usd per share)
Exercised (in usd per share)	18.79
Forfeited/Expired (in usd per share)	18.22
Outstanding at end of period (in usd per share)	19.22
Vested or expected to vest at end of period (in usd per share)	19.22
Exercisable at end of period (in usd per share)	$ 19.22
Weighted Average Remaining Contractual Life
Outstanding, weighted average remaining contractual life	3 years 9 months 18 days
Vested, remaining contractual life	3 years 9 months 18 days
Exercisable, weighted average remaining contractual life	3 years 9 months 18 days
Aggregate Intrinsic Value
Outstanding at end of period	$ 1,896
Vested or expected to vest at end of period	1,896
Exercisable at end of period	$ 1,896
Stock Options
Stock Options, [Roll Forward]
Exercised (in shares)	(857,893)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Total intrinsic value of options exercised	$ 4,200	$ 500
Fair value of stock options vested		$ 400

Stock-Based Compensation - Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Grants (in shares)	28,826	25,326
Granted (in usd per share)	$ 18.79	$ 19.02
Nonvested (in shares)	21,774
Vested (in usd per share)	$ 17.08
Cash paid to settle vested units	$ 800
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants (in shares)	32,322

Stock-Based Compensation - Performance Share Awards (Details) - Performance Shares - USD ($) $ / shares in Units, $ in Millions				3 Months Ended		6 Months Ended
	Dec. 02, 2020	Dec. 05, 2019	Dec. 05, 2018	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares settled in cash						100.00%
Performance shares granted	65,300	55,900	132,400
Return On Net Assets	$ 20.68	$ 19.40	$ 13.63
Performance shares forfeited	0	5,300	40,900
Performance shares compensation expense				$ 0.6	$ 0.1	$ 3.3	$ (0.4)
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting percentage maximum						0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting percentage maximum						200.00%

Stock-Based Compensation - Performance Restricted Stock Units (Details) - Performance Restricted Stock Units - USD ($) $ / shares in Units, $ in Millions				3 Months Ended		6 Months Ended
	Dec. 02, 2020	Dec. 05, 2019	Dec. 05, 2018	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period						3 years
Performance restricted stock units settled in cash						100.00%
Performance Restricted Stock Units Granted	38,400	35,000	89,200
Granted (in usd per share)	$ 20.68	$ 19.40	$ 13.63
Performance restricted stock units shares forfeited	0	0	25,500
Vested (in shares)						32,322
Share-based Payment Arrangement, Expense				$ 0.2	$ 0.1	$ 0.4	$ 0.3
Performance restricted stock units as probable to vest				91,460		91,460
Level 1 [Member] \| A-TSR greater than or equal to 50% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						150.00%
Level 2 [Member] \| A-TSR less than 50% and greater than or equal to 20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						100.00%
Level 3 [Member] \| A-TSR less than 20% and greater than or equal to -20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						50.00%
Level 4 [Member] \| A-TSR less than -20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						0.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						150.00%

Stock-Based Compensation - Treasury Shares (Details)	6 Months Ended
Stock-Based Compensation - Treasury Shares (Details)	Apr. 30, 2021 shares
Treasury Stock [Abstract]
Beginning Balance as of November 1, 2020	(4,491,429)
Stock options exercised	(857,893)
Treasury stock repurchases	157,051
Balance at April 30, 2021	3,684,965
Restricted Stock Awards (RSAs)
Treasury Stock [Abstract]
Restricted stock awards granted	(73,300)
Performance Shares
Treasury Stock [Abstract]
Restricted stock awards granted	(32,322)
Stock Options
Treasury Stock [Abstract]
Stock options exercised	(857,893)

Other Income (Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Other Income (Expense) (Details) - USD ($) $ in Thousands	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Other Income and Expenses [Abstract]
Foreign currency transaction gains (losses)	$ (4)	$ 132	$ (82)	$ 83
Foreign currency derivative losses	0	(4)	0	(15)
Pension service benefit	265	127	530	217
Interest income	1	14	4	19
Other	3	31	5	32
Other, net	$ 265	$ 300	$ 457	$ 336

Segment Information (Details) $ in Millions	3 Months Ended		6 Months Ended
Segment Information (Details) $ in Millions	Apr. 30, 2021 USD ($)	Apr. 30, 2020 USD ($)	Apr. 30, 2021 USD ($) segment	Apr. 30, 2020 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments			3
Allocated corporate general and administrative expense \| $	$ 5.4	$ 4.6	$ 10.7	$ 10.2
Operating Segments \| NA Fenestration
Segment Reporting Information [Line Items]
Number of operating segments			3

Segment Information Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020	Oct. 31, 2020
Segment Reporting Information [Line Items]
Net sales	$ 270,357	$ 187,475	$ 500,504	$ 384,072
Depreciation and amortization	10,845	11,886	21,860	24,791
Operating income (loss)	21,380	8,893	33,215	10,873
Capital expenditures	4,553	7,001	9,799	16,313
Total assets	715,572		715,572		$ 691,585
Operating Segments \| NA Fenestration
Segment Reporting Information [Line Items]
Net sales	146,143	108,593	274,259	219,045
Depreciation and amortization	4,846	5,961	9,957	12,940
Operating income (loss)	15,783	7,428	26,986	9,058
Capital expenditures	2,001	4,308	4,821	11,236
Total assets	261,311		261,311		252,703
Operating Segments \| EU Fenestration
Segment Reporting Information [Line Items]
Net sales	61,657	29,200	110,748	65,966
Depreciation and amortization	2,607	2,330	5,125	4,738
Operating income (loss)	10,250	612	18,437	3,776
Capital expenditures	1,268	407	1,740	1,626
Total assets	238,109		238,109		223,248
Operating Segments \| NA Cabinet Components
Segment Reporting Information [Line Items]
Net sales	63,562	50,664	117,556	100,708
Depreciation and amortization	3,305	3,474	6,575	6,875
Operating income (loss)	(284)	(1,174)	(297)	(3,288)
Capital expenditures	1,160	2,269	3,113	3,344
Total assets	175,769		175,769		174,713
Corporate Non-Segment
Segment Reporting Information [Line Items]
Net sales	(1,005)	(982)	(2,059)	(1,647)
Depreciation and amortization	87	121	203	238
Operating income (loss)	(4,369)	2,027	(11,911)	1,327
Capital expenditures	124	$ 17	125	$ 107
Total assets	$ 40,383		$ 40,383		$ 40,921

Segment Information Goodwill by Segment (Details) $ in Thousands	6 Months Ended
	Apr. 30, 2021 USD ($)
Goodwill [Line Items]
Beginning balance	$ 146,154
Foreign currency translation adjustment	4,148
Balance as of the end of the period	150,302
Operating Segments \| NA Fenestration
Goodwill [Line Items]
Beginning balance	38,712
Foreign currency translation adjustment	0
Balance as of the end of the period	38,712
Operating Segments \| EU Fenestration
Goodwill [Line Items]
Beginning balance	68,295
Foreign currency translation adjustment	4,148
Balance as of the end of the period	72,443
Operating Segments \| NA Cabinet Components
Goodwill [Line Items]
Beginning balance	39,147
Foreign currency translation adjustment	0
Balance as of the end of the period	39,147
Corporate Non-Segment
Goodwill [Line Items]
Beginning balance	0
Foreign currency translation adjustment	0
Balance as of the end of the period	$ 0

Segment Information Reconcilliation of Operating Loss to Net Income (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Apr. 30, 2021	Jan. 31, 2021	Apr. 30, 2020	Jan. 31, 2020	Apr. 30, 2021	Apr. 30, 2020
Segment Reporting [Abstract]
Operating income	$ 21,380		$ 8,893		$ 33,215	$ 10,873
Interest expense	(640)		(1,563)		(1,391)	(3,145)
Other, net	265		300		457	336
Income tax expense	(6,454)		(2,129)		(9,878)	(2,553)
Net income	$ 14,551	$ 7,852	$ 5,501	$ 10	$ 22,403	$ 5,511

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2021	Apr. 30, 2020	Apr. 30, 2021	Apr. 30, 2020
Earnings Per Share Disclosure [Line Items]
Basic earnings per common share	$ 14,551	$ 5,501	$ 22,403	$ 5,511
Diluted earnings per common share	$ 14,551	$ 5,501	$ 22,403	$ 5,511
Basic (in shares)	33,355,000	32,676,000	33,110,000	32,770,000
Diluted (in shares)	33,637,000	32,793,000	33,444,000	32,907,000
Basic earnings per common share	$ 0.44	$ 0.17	$ 0.68	$ 0.17
Diluted earnings per common share	$ 0.43	$ 0.17	$ 0.67	$ 0.17
Antidilutive securities (in shares)	0	1,225,000	0	1,167,000
Stock Options
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	78,000	1,000	135,000	12,000
Antidilutive securities (in shares)	0	1,174,000	0	1,116,000
Restricted Stock Awards (RSAs)
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	112,000	73,000	108,000	83,000
Antidilutive securities (in shares)	0	51,000	0	51,000
Performance Shares
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment		18,000		17,000
Performance Restricted Stock Units
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	92,000	25,000	91,000	25,000